MENU
+Compare
EXHI
Stock ticker: OTC
AS OF
Jun 27 closing price
Price
$0.60
Change
+$0.09 (+17.65%)

EXHI stock forecast, quote, news & analysis

Exlites Holdings International Inc is engaged in the consumer healthcare market and durable medical supply business... Show more

EXHI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for EXHI with price predictions
Jul 03, 2025

EXHI sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for EXHI moved above the 200-day moving average on June 05, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 12, 2025. You may want to consider a long position or call options on EXHI as a result. In of 53 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for EXHI just turned positive on June 18, 2025. Looking at past instances where EXHI's MACD turned positive, the stock continued to rise in of 33 cases over the following month. The odds of a continued upward trend are .

EXHI moved above its 50-day moving average on June 25, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for EXHI crossed bullishly above the 50-day moving average on June 27, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. EXHI’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (7.892). EXHI has a moderately low P/E Ratio (0.000) as compared to the industry average of (29.460). EXHI's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (4.521). EXHI has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.032). P/S Ratio (0.000) is also within normal values, averaging (35.215).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EXHI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are McKesson Corp (NYSE:MCK).

Industry description

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

Market Cap

The average market capitalization across the Medical Distributors Industry is 10.22B. The market cap for tickers in the group ranges from 494.39K to 70.55B. MCK holds the highest valuation in this group at 70.55B. The lowest valued company is SNYR at 494.39K.

High and low price notable news

The average weekly price growth across all stocks in the Medical Distributors Industry was 2%. For the same Industry, the average monthly price growth was 8%, and the average quarterly price growth was -2%. SNYR experienced the highest price growth at 30%, while ZYXI experienced the biggest fall at -8%.

Volume

The average weekly volume growth across all stocks in the Medical Distributors Industry was -57%. For the same stocks of the Industry, the average monthly volume growth was -65% and the average quarterly volume growth was -48%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 62
Price Growth Rating: 55
SMR Rating: 81
Profit Risk Rating: 81
Seasonality Score: -26 (-100 ... +100)
View a ticker or compare two or three
EXHI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry MedicalDistributors

Profile
Fundamentals
Details
Industry
N/A
Address
8403 Benjamin Road
Phone
+1 813 321-9551
Employees
3
Web
https://www.exlitesholdings.us